Xcout Intel
Syantra Diagnostics competitors & alternatives
The 12 closest competitors and alternatives to Syantra Diagnostics among biotech companies — ranked by similarity to what Syantra Diagnostics actually does, not by market-cap band.
Subscribe to see Syantra Diagnostics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Syantra Diagnostics
Syantra Diagnostics, based in Calgary, Canada, is developing a blood-based diagnostic test for breast cancer. This revolutionary test aims to be rapid, economical, and accurate, regardless of various factors, to improve breast cancer detection.
Syantra Diagnostics at a glance
Syantra Diagnostics is a biotech company headquartered in Canada. Xcout tracks 14 named people at Syantra Diagnostics, including Rob Lozuk (Chief Executive Officer).
Syantra Diagnostics leadership
- Rob LozukChief Executive Officer
- Francine StirlingChief of Staff
- Bob ShepherdCo-Founder & Chief Operating Officer
- Kristina Rinker, PhD, PEngCo-Founder & Chief Scientific Officer
- Kenneth Fuh, PhD, MLTCo-Founder & Director, Product Development
- Randy Moore, MD FRCSC FACSCo-Founder & Medical Director
8 more named people on record for Syantra Diagnostics, with roles, board committees and tenure — see the full roster →
Top 12 Syantra Diagnostics competitors
Ranked by semantic similarity — how close each company is to Syantra Diagnostics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Signatur Biosciences develops a molecular diagnostic platform that utilizes standard qPCR equipment to analyze complex RNA signatures and perform precision testing for diseases such as breast cancer. The company's kits are designed to decentralize diagnostics by replacing complex, expensive laboratory workflows with simplified assays compatible with existing hospital infrastructure.
Medical - Diagnostics & Research
Biodesix, Inc. is a public diagnostic solutions company founded in 2006 and headquartered in Louisville, Colorado. The company specializes in diagnostic testing and development services focused on discovering blood-based tests for cancer management.
Biotechnology
SAGA Diagnostics provides ultra-sensitive, blood-based molecular residual disease (MRD) detection and monitoring tests for cancer patients. The company's flagship platform, Pathlight, uses tumor whole-genome sequencing and personalized digital PCR assays to detect circulating tumor DNA, primarily serving clinicians and biopharmaceutical partners for early cancer detection and treatment tracking.
Life Sciences
PinkDx, Inc., also known as The Gyne Cancer Company, is headquartered in San Francisco, California. The company specializes in advanced gynecologic cancer diagnostics and developing innovative patient testing solutions.
Biotechnology
MDNA Life Sciences, Inc. develops non-invasive, blood-based diagnostic tests utilizing patented mitochondrial DNA technology to detect diseases such as cancer at early stages. The company serves patients and healthcare providers by offering accurate screening solutions designed to improve disease detection and reduce the need for unnecessary invasive surgeries.
Biotechnology
Capio Biosciences is an oncology diagnostics company that develops advanced technologies for capturing and analyzing circulating tumor cells (CTCs) from whole blood. Its proprietary CapioCyte platform offers enhanced sensitivity compared to traditional methods, serving as a research tool designed to help oncologists make informed cancer treatment decisions.
Biotechnology
Owlstone Inc. is a diagnostics-focused company that works in the field of breath-based testing and breath biopsy diagnostics.
Biotechnology
Hera Therapeutics Inc. is a women's health diagnostics company that develops non-invasive, AI-powered tools for the detection and staging of endometriosis and cervical cancer. The company serves patients and clinicians in OB-GYN, fertility, and drug discovery fields by providing molecular tests and point-of-care diagnostic devices designed to replace invasive procedures.
Biotechnology & Healthcare
Protean BioDiagnostics Inc. is a diagnostic company based in the United States that provides advanced cancer profiling systems and laboratory testing services.
Similar biotech company
Precede Biosciences is a biotechnology company developing blood-based liquid-biopsy technologies for molecular profiling of cancer. Its tests are intended to support oncology research, precision treatment decisions, and pharmaceutical drug-development programs.
Biotechnology
Predicta Biosciences is a precision oncology company that builds a molecular insights platform for blood cancer care. By utilizing a single blood sample, the company integrates multiomics and liquid biopsies to generate longitudinal genomic and immune insights for diagnostics.
Biotechnology
Nexosome Oncology Holdings, Inc. develops blood tests for early-stage cancer detection using patented extracellular vesicle proteomics and AI/ML biomarker discovery. The company serves patients and healthcare partners by providing highly accurate diagnostic tools.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Syantra Diagnostics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Syantra Diagnosticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →